These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33360966)

  • 1. Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
    Morris E; Batallones R; Ryan J; Slomp C; Carrion P; Albert A; Austin J
    Psychiatry Res; 2021 Feb; 296():113663. PubMed ID: 33360966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness.
    Valenstein M; Kavanagh J; Lee T; Reilly P; Dalack GW; Grabowski J; Smelson D; Ronis DL; Ganoczy D; Woltmann E; Metreger T; Wolschon P; Jensen A; Poddig B; Blow FC
    Schizophr Bull; 2011 Jul; 37(4):727-36. PubMed ID: 19933540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.
    Wilder CM; Elbogen EB; Moser LL; Swanson JW; Swartz MS
    Psychiatr Serv; 2010 Apr; 61(4):380-5. PubMed ID: 20360277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological challenges in psychiatric treatment adherence research.
    Velligan D; Sajatovic M; Valenstein M; Riley WT; Safren S; Lewis-Fernandez R; Weiden P; Ogedegbe G; Jamison J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):74-91. PubMed ID: 20643631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing medication attitudes and reasons for medication nonadherence among three disparate groups of individuals with serious mental illness.
    Levin JB; Seifi N; Cassidy KA; Tatsuoka C; Sams J; Akagi KK; Sajatovic M
    J Nerv Ment Dis; 2014 Nov; 202(11):769-73. PubMed ID: 25357252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of mental illness and criminality self-stigmas and racial self-concept on outcomes in a forensic psychiatric sample.
    West ML; Vayshenker B; Rotter M; Yanos PT
    Psychiatr Rehabil J; 2015 Jun; 38(2):150-157. PubMed ID: 25938621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment.
    Soni S; Whittington J; Holland AJ; Webb T; Maina E; Boer H; Clarke D
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):32-42. PubMed ID: 17181601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with schizophrenia in Morocco during the COVID-19 pandemic: a longitudinal observational study.
    Doufik J; Lahlou L; al'Absi M; Benhamida J; Laaraj H; Ouhamou M; El Oumary O; Salehddine Z; Mouhadi K; Rammouz I
    East Asian Arch Psychiatry; 2024 Mar; 34(1):3-8. PubMed ID: 38955777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of psychotropic medication adherence among HIV+ individuals living with bipolar disorder.
    Casaletto KB; Kwan S; Montoya JL; Obermeit LC; Gouaux B; Poquette A; Heaton RK; Atkinson JH; Moore DJ;
    Int J Psychiatry Med; 2016; 51(1):69-83. PubMed ID: 26681237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice.
    Roe D; Goldblatt H; Baloush-Klienman V; Swarbrick M; Davidson L
    Psychiatr Rehabil J; 2009; 33(1):38-46. PubMed ID: 19592378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.
    Novick D; Montgomery W; Treuer T; Aguado J; Kraemer S; Haro JM
    BMC Psychiatry; 2015 Aug; 15():189. PubMed ID: 26239486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis.
    Semahegn A; Torpey K; Manu A; Assefa N; Tesfaye G; Ankomah A
    Syst Rev; 2020 Jan; 9(1):17. PubMed ID: 31948489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to Improve Pharmacological Adherence Among Adults With Psychotic Spectrum Disorders and Bipolar Disorder: A Systematic Review.
    Hartung D; Low A; Jindai K; Mansoor D; Judge M; Mendelson A; Kansagara D; Motu Apuaka M; Freeman M; Kondo K
    Psychosomatics; 2017; 58(2):101-112. PubMed ID: 28139249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.
    Fond G; Boyer L; Boucekine M; Aden LA; Schürhoff F; Tessier A; Andrianarisoa M; Berna F; Brunel L; Capdevielle D; Chereau I; Mallet J; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Misdrahi D;
    Schizophr Res; 2017 Apr; 182():84-89. PubMed ID: 27789187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encouraging patients to take medication as prescribed. Two recent reviews offer advice about assessing and improving treatment adherence.
    Harv Ment Health Lett; 2010 Jan; 26(7):4-5. PubMed ID: 20213933
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness.
    Hayes JF; Lundin A; Wicks S; Lewis G; Wong ICK; Osborn DPJ; Dalman C
    JAMA Psychiatry; 2019 Apr; 76(4):382-390. PubMed ID: 30624557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.